BRAF and melanoma: Meanwhile, proliferation and CD69 expression of NK cells are increased in the context of IL-2, which is important for NK cells to reinforce the antitumor activity of BRAF inhibitor by perforin-dependent pathway in a BRAF-mutant melanoma mouse model (143).